In recent years, the integration of light-responsive nanomaterials into biomedical applications has heralded a new era in combating bacterial biofilms, especially those associated with orthopedic implants. However, conventional plasmonic nanozymes often succumb to pronounced limitations, notably the fleeting existence of photoexcited carriers and their restricted activation under ultraviolet-visible (UV-Vis) light. This spectral constraint significantly hinders their therapeutic functionality in deep tissue due to inadequate light penetration. Addressing these challenges calls for innovative design strategies that enhance plasmonic catalysis within biologically relevant environments.
A breakthrough study recently published in Light: Science & Applications reports on the engineering of a novel near-infrared II (NIR-II) light-responsive plasmonic nanozyme that exhibits unparalleled performance in eradicating hypoxic bacterial biofilms, a notoriously difficult problem in implant-related infections. Spearheaded by Professor Jin-Wen Liu and collaborators at Guangxi Medical University, this work unveils an advanced nanostructure comprising gold nanobipyramids augmented with platinum nanoparticles at their tips, creating what is termed as ePt-Au NBPs.
The carefully engineered architecture of ePt-Au NBPs leverages the synergistic interaction between gold and platinum at the nanoscale, resulting in transformative optical and catalytic properties. Crucially, the tip-localized platinum nanoparticles induce a significant redshift of the localized surface plasmon resonance (LSPR) peak, transitioning its responsiveness from the traditional UV-Vis window into the NIR-II spectrum (1000–1700 nm). This spectral shift is of paramount importance for biomedical applications, as NIR-II light exhibits superior tissue penetration and minimal phototoxicity compared to UV or visible light, enabling effective treatment of infections situated deep beneath the skin.
Beyond spectral tuning, the presence of platinum promotes efficient charge separation and facilitates highly optimized electron transfer dynamics. This results in a remarkable augmentation of hot electron generation within the plasmonic nanozyme, a critical factor for boosting catalytic activity. These hot carriers under NIR-II irradiation actively catalyze the production of reactive oxygen species (ROS), particularly hydroxyl radicals (•OH), which are potent agents in disrupting biofilm matrix components.
The study meticulously elucidates the mechanism underpinning the nanozyme’s biofilm eradication capability. The hydroxyl radicals target extracellular DNA (eDNA), an essential scaffolding molecule that maintains biofilm structural integrity within the extracellular polymeric substance (EPS). By degrading eDNA, the nanozyme destabilizes the biofilm matrix, rendering it vulnerable to further therapeutic interventions. Simultaneously, localized hyperthermia generated by NIR-II-triggered plasmon resonance enhances bacterial killing efficacy, penetrating the compromised biofilm even in oxygen-poor, hypoxic environments where traditional antibiotics falter.
Importantly, biofilm eradication constitutes only one facet of the nanozyme’s functional repertoire. Surface functionalization with RGDC peptides significantly expands its biomedical applicability by promoting biocompatibility and osteogenic differentiation. The RGDC motif, recognized for its affinity toward integrin receptors on osteoblasts, facilitates enhanced cell adhesion and proliferation. This dual-functionality of antimicrobial action combined with stimulated bone regeneration positions ePt-Au NBPs/RGDC as a promising smart coating material tailored for orthopedic implants.
The implications of this work are far-reaching. Implant-associated infections represent a major clinical challenge, often leading to implant failure and necessitating revision surgeries. Conventional antimicrobial treatments are limited by poor biofilm penetration and the emergence of antibiotic resistance. The advent of plasmonic nanozymes activated within the NIR-II window offers a paradigm shift by circumventing these limitations with non-invasive, efficient, and targeted therapies that simultaneously promote implant integration.
Furthermore, the study’s innovative nanoengineering strategy highlights the importance of tip-localized modifications in plasmonic nanostructures, a design principle with potential applications beyond antibacterial therapy. By exploiting localized electromagnetic field enhancement at nanoparticle tips, the research underscores a versatile platform for catalysis and phototherapy that may be adapted to other nanomaterials and therapeutic targets.
From a materials science perspective, the synthesis of ePt-Au NBPs involves precise control over nanoparticle morphology and functionalization, enabling reproducibility and scalability—key factors for clinical translation. The use of gold provides chemical stability and biocompatibility, whereas platinum serves as an electron sink, honing the catalytic properties that are crucial for the generation of reactive oxygen species under NIR-II irradiation.
This work complements and extends the growing field of nanozyme research, where enzyme-mimicking nanomaterials partnered with light activation offer new routes for tackling infectious diseases. By harnessing the photothermal and photocatalytic effects within a single nanoplatform, the ePt-Au NBPs/RGDC system exemplifies multifunctional nanomedicine designed to overcome the complex and adaptive nature of bacterial biofilms.
Looking ahead, the researchers emphasize that further in vivo investigations and biocompatibility assessments will be essential to translate this technology from bench to bedside. Moreover, the potential customization of surface peptides and exploration of other plasmonic metals may broaden the clinical scope of these nanozymes, including applications in wound healing, cancer therapy, and beyond.
In summary, this pioneering study offers a compelling solution to one of the most intractable biomedical problems — implant-associated biofilm infections — through the lens of advanced plasmonic nanomaterials activated by NIR-II light. The dual-action mechanism combining oxidative biofilm disruption and thermal bacterial eradication, together with pro-osteogenic surface functionality, heralds a new frontier in smart implant coatings that promise enhanced patient outcomes and reduced healthcare burden.
Subject of Research: Engineering NIR-II Responsive Plasmonic Nanozymes for Biofilm Eradication and Bone Repair
Article Title: NIR-II-triggered plasmonic catalysis with tip-localized enhancement: a strategy for hypoxic biofilm eradication on orthopedic implants
Web References: DOI: 10.1038/s41377-026-02279-5
Image Credits: Yingfeng Qin et al.
Keywords
NIR-II plasmonic nanozymes, biofilm eradication, bacterial hypoxia, gold nanobipyramids, platinum nanoparticles, localized surface plasmon resonance, hot electron catalysis, hydroxyl radicals, hyperthermia, orthopedic implants, RGDC peptide, bone regeneration
Tags: antibacterial nanomaterials for implantsbiomedical applications of plasmonic nanozymesdeep tissue light penetration in therapygold-platinum nanozymeshypoxic biofilm treatment on implantslocalized surface plasmon resonance redshiftnanobipyramid plasmonic structuresNIR-II light-responsive nanozymesorthopedic implant infection solutionsphotoexcited carrier lifetime extensionplasmonic catalysis for biofilm eradicationtip-localized plasmonic enhancement
